Comparison of the predictive performance of Cumulative Illness Rating Scale, Charlson Comorbidity Index and COMCOLD Index for moderate-to-severe exacerbations in elderly subjects with chronic obstructive pulmonary disease

TL;DR

This study found that the CIRS tool better predicts COPD exacerbations in elderly patients compared to other comorbidity indices.

Contribution

The study demonstrates that CIRS outperforms CCI and COMCOLD in predicting COPD exacerbations due to its comprehensive, severity-weighted approach.

Findings

CIRS indices showed significant associations with COPD exacerbation risk in both crude and adjusted models.

CIRS-SI had the highest time-dependent AUC values at 12, 24, and 52 weeks compared to CCI and COMCOLD.

CIRS provides better prognostic accuracy for COPD exacerbations, supporting its use in clinical practice.

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is frequently associated with multiple comorbidities that influence clinical outcomes. This study aimed to compare the predictive performance of the Cumulative Illness Rating Scale (CIRS) with the Charlson Comorbidity Index (CCI) and COMCOLD Index for moderate-to-severe COPD exacerbations.

We conducted a prospective observational study involving 200 COPD patients followed for 52 weeks. CIRS indices (Total Score, Severity Index, Comorbidity Index), CCI, and COMCOLD were calculated at baseline. The primary outcome was time-to-first moderate-to-severe exacerbation. Cox regression analyses and time-dependent receiver operating characteristic curves were used to assess prognostic performance at 12, 24, and 52 weeks.

During follow-up, 66 patients (33%) experienced at least one moderate-to-severe exacerbation. All CIRS indices demonstrated significant correlations with respiratory parameters and symptom burden. In crude models, CIRS indices were significantly associated with exacerbation risk (CIRS-TS: HR 1.11, 95%CI 1.06–1.16; CIRS-SI: HR 1.16, 95%CI 1.09–1.23; CIRS-CI: HR 1.37, 95%CI 1.20–1.56; all p < 0.001), maintaining significance after adjustment for clinical covariates. CIRS indices demonstrated superior discriminative performance compared to CCI and COMCOLD, with CIRS-SI achieving the highest time-dependent AUC values across all timepoints (0.704, 0.679, and 0.778 at 12, 24, and 52 weeks, respectively).

CIRS provides superior prognostic accuracy compared to established comorbidity indices in identifying COPD patients at increased risk of exacerbations. These findings highlight the clinical relevance of incorporating a comprehensive, severity-weighted comorbidity assessment in COPD management, supporting the concept of COPD as a complex, multisystem disorder requiring an integrated approach to care.

In elderly patients with COPD, CIRS provided superior prognostic accuracy for moderate-to-severe exacerbations compared with the Charlson Comorbidity Index and COMCOLD;

The prognostic advantage of CIRS likely derives from its comprehensive, severity-weighted assessment of multimorbidity across multiple organ systems;

Incorporating multidimensional comorbidity evaluation, such as CIRS, into clinical practice may improve risk stratification and support more personalized COPD management.